CapWealth Advisors LLC Has $24.52 Million Position in CVS Health Corporation (NYSE:CVS)

CapWealth Advisors LLC increased its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 7.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 361,854 shares of the pharmacy operator's stock after acquiring an additional 23,877 shares during the period. CVS Health comprises about 2.7% of CapWealth Advisors LLC's holdings, making the stock its 11th largest holding. CapWealth Advisors LLC's holdings in CVS Health were worth $24,516,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the business. Dodge & Cox lifted its stake in CVS Health by 11.2% in the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after acquiring an additional 7,075,209 shares in the last quarter. Capital World Investors raised its stake in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of CVS Health by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock worth $1,211,582,000 after purchasing an additional 689,867 shares in the last quarter. Capital International Investors raised its stake in shares of CVS Health by 4.8% during the 4th quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock worth $1,196,989,000 after purchasing an additional 1,212,126 shares in the last quarter. Finally, Pzena Investment Management LLC raised its stake in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone purchased 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Performance

CVS traded down $0.89 during midday trading on Friday, reaching $64.73. The company's stock had a trading volume of 7,020,831 shares, compared to its average volume of 10,796,063. The stock has a market cap of $81.88 billion, a P/E ratio of 15.45, a PEG ratio of 0.94 and a beta of 0.57. The company has a fifty day simple moving average of $65.05 and a 200 day simple moving average of $62.22. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last released its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company's revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.31 EPS. Research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be paid a $0.665 dividend. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.11%. CVS Health's payout ratio is 63.48%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CVS shares. Jefferies Financial Group raised their price target on CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Barclays set a $79.00 price target on CVS Health and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Morgan Stanley reaffirmed an "overweight" rating on shares of CVS Health in a research note on Tuesday, April 15th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Finally, Truist Financial increased their price objective on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a report on Monday, May 12th. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and an average target price of $75.06.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.